Parathyroid hormone signaling via Gαs is selectively inhibited by an NH 2-terminally truncated Gαs: Implications for pseudohypoparathyroidism

Journal of Bone and Mineral Research

Volumn 26, Issue 10, 2011, Pages 2473-2485

  Puzhko, Svetlana ^a   Goodyer, Cynthia Gates ^a,b   Kerachian, Mohammad Amin ^b,c   Canaff, Lucie ^c   Misra, Madhusmita ^d,e   Jüppner, Harald ^d,e   Bastepe, Murat ^d   Hendy, Geoffrey N ^b,c  

^a RESEARCH INSTITUTE OF THE MCGILL UNIVERSITY HEALTH CENTRE   (Canada)

^b MCGILL UNIVERSITY   (Canada)

^c ROYAL VICTORIA HOSPITAL   (Canada)

^d MASSACHUSETTS GENERAL HOSPITAL   (United States)

^e HARVARD MEDICAL SCHOOL   (United States)

Author keywords

albright hereditary osteodystrophy; cyclic AMP; parathyroid hormone; pseudohypoparathyroidism; stimulatory G protein

Indexed keywords

ADENYLATE CYCLASE; ARGIPRESSIN RECEPTOR; BETA 2 ADRENERGIC RECEPTOR; CYCLIC AMP; GUANINE NUCLEOTIDE BINDING PROTEIN ALPHA SUBUNIT; ISOPRENALINE; LEVOTHYROXINE; PARATHYROID HORMONE; PARATHYROID HORMONE RECEPTOR 1; THYROTROPIN RECEPTOR;

ALBRIGHT SYNDROME; ALLELE; AMINO TERMINAL SEQUENCE; ANIMAL CELL; ARTICLE; CODON; EXON; FEMALE; GENE MUTATION; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; HUMAN TISSUE; INFANT; NONHUMAN; OPOSSUM; PROTEIN EXPRESSION; PSEUDOHYPOPARATHYROIDISM; SIGNAL TRANSDUCTION;

BLOTTING, WESTERN; CELL LINE; CYCLIC AMP; GTP-BINDING PROTEINS; HUMANS; PARATHYROID HORMONE; PSEUDOHYPOPARATHYROIDISM; SIGNAL TRANSDUCTION;

EID: 80053178756     PISSN: 08840431     EISSN: 15234681     Source Type: Journal    
DOI: 10.1002/jbmr.461     Document Type: Article

References (46)

1. Bastepe M, Jüppner H,. Perspectives: pseudohypoparathyroidism, Gsα, and the GNAS locus. BoneKEy-Osteovision. 2005; 2: 20-32.
2. Levine MA., Pseudohypoparathyroidism. In:, JP Bilezikian, LG Raisz, GA Rodan, eds. Principles of bone biology, vol 2. New York: Academic Press; 2002, pp 1137-63.
3. Albright F, Burnett CH, Smith PH,. Pseudohypoparathyroidism: an example of "Seabright-Bantam syndrome." Endocrinology. 1942; 30: 922-32.
4. Albright F, Forbes AP, Henneman PH,. Pseudohypoparathyroidism. Trans Assoc Am Physicians. 1952; 65: 337-50.
5. Weinstein LS, Yu S, Warner DR, Liu J,. Endocrine manifestations of stimulatory G protein α-subunit mutations and the role of genomic imprinting. Endocr Rev. 2001; 22: 675-705. (Pubitemid 32955250)
6. Weinstein LS, Liu J, Sakamoto A, Xie T, Chen M,. GNAS: normal and abnormal functions. Endocrinology. 2004; 145: 5459-64.
7. Liu J, Litman D, Rosenberg MJ, Yu S, Biesecker LG, Weinstein LS,. A GNAS1 imprinting defect in pseudohypoparathyroidism type 1B. J Clin Invest. 2000; 106: 1167-74.
8. Bastepe M, Pincus JE, Sugimoto T, Tojo K, Kanatani M, Azuma Y, Kruse K, Rosenbloom AL, Koshiyama H, Jüppner H,. Positional dissociation between the genetic mutation responsible for pseudohypoparathyroidusm type 1b and the associated methylation defect at exon A/B: evidence for a long-range regulatory element within the imprinted GNAS1 locus. Hum Mol Genet. 2001; 101231-41.
9. Bastepe M,. The GNAS locus and pseudohypoparathyroidism. Adv Exp Med Biol. 2008; 626: 27-40.
10. Mantovani G, Maghnie M, Weber G, DeMenis E, Brunelli V, Cappa M, Loli P, Beck-Peccoz P, Spada A,. Growth hormone-releasing hormone resistance in pseudohypoparathyroidism type Ia: new evidence for imprinting of the Gs α gene. J Clin Endocrinol Metab. 2003; 88: 4070-4. (Pubitemid 37153698)
11. Germain-Lee EL, Groman J, Crane JL, Jan de Beur SM, Levine MA,. Growth hormone deficiency in pseudohypoparathyroidism type 1a: another manifestation of multihormone resistance. J Clin Endocrinol Metab. 2003; 88: 4059-69. (Pubitemid 37158030)
12. Zheng H, Radeva G, McCann JA, Hendy GN, Goodyer CG,. Gαs transcripts are biallelically expressed in human kidney cortex: implications for pseudohypoparathyroidism type 1b. J Clin Endocrinol Metab. 2001; 86: 4627-9. (Pubitemid 33020497)
13. Mantovani G, Bondioni S, Locatelli M, Pedroni C, Lania AG, Ferrante E, Filopanti M, Beck-Peccoz P, Spada A,. Biallelic expression of the Gsα in human bone and adipose tissue. J Clin Endocrinol Metab. 2004; 89: 6316-9. (Pubitemid 39628452)
14. Hayward BE, Moran V, Strain L, Bonthron DT,. Bidirectional imprinting of a single gene. GNAS1 encodes maternally, paternally, and biallelically derived proteins. Proc Natl Acad Sci USA. 1998; 95: 15475-80. (Pubitemid 29018723)
15. Peters J, Wroe SF, Wells CA, Miller HJ, Bodle D, Beechey CV, Williamson CM, Kelsey G,. A cluster of oppositely imprinted transcript at the Gnas locus in the distal imprinting region of mouse chromosome 2. Proc Natl Acad Sci USA. 1999; 96: 3830-5. (Pubitemid 29168996)
16. Kehlenbach RH, Matthey J, Huttner WB,. XLαs is a new type of G protein. Nature. 1994; 372: 804-9.
17. Klemke M, Pasolli HA, Kehlenbach RH, Offermanns S, Schultz G, Huttner WB,. Characterization of the extra-large G protein α-subunit Xlas: II. Signal transduction properties. J Biol Chem. 2000; 275: 33633-40.
18. Bastepe M, Gunes Y, Perez-Villamil B, Hunzelman J, Weinstein Lee S, Jüppner H,. Receptor-mediated adenylyl cyclase activation through XLαs, the extra-large variant of the stimulatory G protein α-subunit. Mol Endocrinol. 2002; 16: 1912-9. (Pubitemid 34828097)
19. Linglart A, Mahon MJ, Kerachian MA, Berlach DM, Hendy GN, Jüppner H, Bastepe M,. Coding GNAS mutations leading to hormone resistance impair in vitro agonist- and cholera toxin-induced adenosine cyclic 3',5'-monophoshate formation mediated by human XLαs. Endocrinology. 2006; 147: 2253-62.
20. Ischia R, Lovisetti-Scamihorn P, Hogue-Angeletti R, Wolkersdorfer M, Winkler H, Fischer-Coldbrie R,. Molecular cloning and characterization of NESP55, a novel chromogranin-like precursor of a peptide with 5-HT1B receptor antagonist activity. J Biol Chem. 1997; 272: 11657-62. (Pubitemid 27184179)
21. Ishikawa Y, Bianchi C, Nadal-Ginard B, Moncy CJ,. Alternative promoter and 5' exon generate a novel Gsa mRNA. J Biol Chem. 1990; 265: 8458-62.
22. Swaroop A, Agarwal N, Gruen JR, Bick D, Weissman SM,. Differential expression of novel Gαs signal transduction protein cDNA species. Nucleic Acids Res. 1991; 19: 4725-9. (Pubitemid 21912856)
23. Greulich WW, Pyle SI., Radiographic atlas of skeletal development of the hand and wrist, 2nd ed. Stanford, CA, USA: Stanford University Press; 1959, 125-83.
24. Steinbach HL, Young DA,. The roentgen appearance of pseudohypoparathyroidism (PH) and pseudo-pseudohypoparathyroidism. (PPH). Am J Roentgenol Radium Ther Nucl Med. 1966; 97: 49-66.
25. Miric A, Vechio JD, Levine MA,. Heterogeneous mutations in the gene encoding the α-subunit of the stimulatory G protein of adenylyl cyclase in Albright hereditary osteodystrophy. J Clin Endocrinol Metab. 1993; 76: 1560-8. (Pubitemid 23164378)
26. Aldred MA, Trembath RC,. Activating and inactivating mutations in the human GNAS1 gene. Hum Mutat. 2000; 16: 183-9.
27. Schipani E, Karga H, Karaplis AC, Potts JT Jr, Kronenberg HM, Segre GV, Abou-Samra AB, Juppner H,. Identical complementary deoxyribonucleic acids encode a human renal and bone parathyroid hormone (PTH)/PTH-related peptide receptor. Endocrinology. 1993; 132: 2157-65. (Pubitemid 23133266)
28. q/11. Thyroid. 2000; 10: 3-10.
29. Barak LS, Oakley RH, Laporte SA, Caron MG,. Constitutive arrestin-mediated desensitization of a human vasopressin receptor mutant associated with nephrogeneic diabetes insipidus. Proc Natl Acad Sci USA. 2001; 98: 93-8. (Pubitemid 32095869)
30. Wu WI, Schwindinger WF, Aparicio LF, Levine MA,. Selective resistance to parathyroid hormone caused by a novel uncoupling mutation in the carboxyl terminus of Gα(s). A cause of pseudohypoparathyroidism type 1b. J Biol Chem. 2001; 276: 65-171.
31. Patten JL, Johns DR, Valle D, Eil C, Gruppuso PA, Steele G, Smallwood PM, Levine MA,. Mutation of the gene encoding the stimulatory G protein of adenylate cyclase in Albright's hereditary osteodystrophy. N Engl J Med. 1990; 322: 1412-9. (Pubitemid 20152526)
32. s in the development of human obesity. J Clin Endocrinol Metab. 2007; 92: 1073-9. (Pubitemid 46465685)
33. Bastepe M,. The GNAS locus: quintessential complex gene encoding Gsα, XLαs, and other imprinted transcripts. Curr Genomics. 2007; 9: 171-80.
34. Jan de Beur SM, Ding C, Germain-Lee E, Cho J, Maret A, Levine MA,. Discordance between genetic and epigenetic defects in pseudohypoparathyroidism type 1b revealed by inconsistent loss of maternal imprinting at GNAS1. Am J Hum Genet. 2003; 73: 314-22. (Pubitemid 36920994)
35. De Nanclares GP, Fernandez-Rebollo E, Santin I, Garcia-Cuartero B, Gaztambide S, Menedez E, Morales J, Pombo M, Bilbao JR, Barros F, Zazo N, Ahrens W, Jüppner H, Hiort O, Castano L, Bastepe M,. Epigenetic defects of GNAS in patients with pseudohypoparathyroidism and mild features of Abright's hereditary osteodystrophy. J Clin Endocronol Metab. 2007; 92: 2370-3. (Pubitemid 46997148)
36. Gilchrist A, Vanhauwe JF, Li A, Thomas TO, Voyno-Yasenetskaya T, Hamm HE,. Gα minigenes expressing C-terminal peptides serve as specific inhibitors of thrombin-mediated endothelial activation. J Biol Chem. 2001; 276: 25672-9.
37. Akhter SA, Luttrell LM, Rockman HA, Iaccarino G, Lefkowitz RJ, Koch WJ,. Targeting the receptor-Gq interface to inhibit in vivo pressure overload myocardial hypertrophy. Science. 1998; 280: 574-7. (Pubitemid 28227758)
38. Feldman DS, Zamah AM, Pierce KL, Miller WE, Kelly F, Rapacciuolo A, Rockman HA, Koch WJ, Luttrell LM,. Selective inhibition of heterotrimeric Gs signaling: targeting the receptor-G protein interface using a peptide minigene encoding the Gα(s) carboxyl terminus. J Biol Chem. 2002; 277: 28631-40. (Pubitemid 41079292)
39. D'Ursi AM, Giusti L, Albrizio S, Porchia F, Esposito C, Caliendo G, Gargini C, Novellino E, Lucacchini A, Rovero P, Mazzoni MR,. A membrane-permeable peptide containing the last 21 residues of the G alpha(s) carboxyl terminus inhibits G(s)-coupled receptor signaling in intact cells: correlations between peptide structure and biological activity. Mol Pharmacol. 2005; 69: 727-36. (Pubitemid 43363847)
40. Hanoune J, Defer N,. Regulation and role of adenylyl cyclase isoforms. Annu Rev Pharmacol Toxicol. 2001; 41: 145-74. (Pubitemid 32385886)
41. Ludwig MG, Seuwen K,. Characterization the human adenylyl cyclase gene family: cDNA, gene structure, and tissue distribution of the nine isoforms. J Recept Signal Transduct Res. 2002; 22: 79-110. (Pubitemid 36169141)
42. Cabrera-Vera TM, Vanhauwe J, Thomas TO, Medkova M, Preininger A, Mazzoni MR, Hamm HE,. Insights into G protein structure, function, and regulation. Endocr Rev. 2003; 24: 765-81. (Pubitemid 38067698)
43. 2-adrenoceptors to XLαs and Gαs: a new insight into ligand-induced G protein activation. J Pharmacol Exp Ther. 2009; 329: 350-9.
44. Aydin C, Aytan N, Mahon MJ, Tawfeek HA, Kowall HA, Dedeoglu A, Bastepe M,. Extralarge XLαs (XXLαs), a variant of stimulatory G protein α-subunit (Gsα), is a distinct, membrane-anchored GNAS product that can mimic Gsα. Endocrinology. 2009; 150: 3567-75.
45. Plagge A, Gordon E, Dean W, Boiani R, Cinti S, Peters J, Kelsey G,. The imprinted signalling protein XLαs is required for postnatal adaptation to feeding. Nat Genet. 2004; 36: 818-26. (Pubitemid 39014098)
46. Xie T, Plagge A, Gavrilova O, Pack S, Jou W, Lai EW, Fronetra M, Kelsey G, Weinstein LS,. The alternative stimulatory G protein α-subunit is a critical regulator of energy and glucose metabolism and sympathetic nerve activity in adult mice. J Biol Chem. 2006; 281: 18989-99. (Pubitemid 44035402)